Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry


ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?

Author(s): Andrea Bortolato, Giorgio Cozza and Stefano Moro

Volume 8, Issue 7, 2008

Page: [798 - 806] Pages: 9

DOI: 10.2174/187152008785914761

Price: $65


Protein kinase CK2 is a ubiquitous, essential, and highly pleiotropic protein kinase whose abnormally high constitutive activity is suspected to underlie its pathogenic potential in neoplasia and other diseases. A number of structurally unrelated CK2 inhibitors, tested on a variety of cells derived from tumours, including lymphomas, leukaemias, multiple myeloma and prostate carcinoma, display a proapoptotic effect which is roughly proportional to their in vitro inhibitory potency. In the present review we summarize the most recent discovery of potent and selective CK2 inhibitors and their prospective as future anticancer agents.

Keywords: Protein kinase CK2, casein kinase 2, anticancer drugs, drug discovery

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy